Daily news about corporate social responsibility, ethics and sustainability
Tags (3) : targeted therapy
Nuvation Bio's Taletrectinib Clears Key UK Regulatory Milestone for ROS1+ Lung Cancer
06/29/2026 | Companies
AACR Annual Meeting,
advanced lung cancer,
biotech,
cancer drug development,
cancer therapy,
cancer treatment advancements,
DOVBLERON,
Eisai,
Eisai partnership,
EMA,
European Medicines Agency,
FDA approval,
global healthcare,
IBTROZI,
International Recognition Procedure,
Journal of Clinical Oncology,
lung cancer research,
MAA,
Marketing Authorisation Application,
metastatic cancer treatment,
MHRA,
non-small cell lung cancer,
NSCLC treatment,
Nuvation Bio,
Nuvation Bio stock,
NYSE NUVB,
oncology,
oncology innovation,
pharmaceutical industry,
Phase 2 clinical trials,
precision medicine,
rare cancer mutations,
respiratory oncology,
ROS1-positive NSCLC,
ROS1+ lung cancer,
taletrectinib,
targeted therapy,
TRUST-I,
TRUST-II,
UK regulatory approval
Mabwell Advances 6MW5311 Bispecific Antibody for AML and Blood Cancers
04/16/2026 | Companies
6MW5311,
acute myeloid leukemia,
AML,
biopharmaceuticals,
biotechnology,
bispecific antibody,
cancer research,
CD3,
chronic myelomonocytic leukemia,
clinical trials,
CMML,
cytotoxicity,
drug development,
FDA,
hematologic malignancies,
immune synapse,
immunotherapy,
IND application,
LILRB4,
Mabwell,
MM,
multiple myeloma,
NMPA,
oncology,
preclinical studies,
stem cell transplantation,
steric hindrance,
T cell engager,
targeted therapy,
TCE technology,
tumor inhibition
Join Team ScottsMiracle-Gro in Pelotonia: Support Cancer Research Through Cycling
09/26/2024 | Companies
Companies
Most Popular Now
Environment News
Compliance
Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com